[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-med] Résultat du 3ème tour du Fonds Mondial
- From: remed@remed.org
- Date: Wed, 22 Oct 2003 09:23:43 -0400 (EDT)
E-MED: Résultat du 3ème tour du Fonds Mondial
---------------------------------------------------------------------
[Modérateur: vous trouverez ci-dessous la dernière lettre du Fonds Mondial
pour le Sida, le Paludisme et la tuberculose avec la liste des pays dont les
projets ont été acceptés pour ce 3ème tour.CB]
GLOBAL FUND OBSERVER (GFO) NEWSLETTER
A service of Aidspan.
Issue 13 ? Sunday 19 October 2003.
Note: For formatted web, Word and PDF versions of this and other issues, see
www.aidspan.org/gfo/archives/newsletter
+ + + + + + + + + + + + + + + + + + +
CONTENTS
+ + + + + + + + + + + + + + + + + + +
* NEWS: Global Fund Approves Third Round of Grants, and Prepares for Round 4
The board has approved Round 3 grants with a 2-year cost of $623 million,
significantly less than expected. Round 4 will be launched on 10 January
2004.
* COMMENTARY: The Need for Technical Assistance
The evidence of Round 3 suggests that the technical merit of proposals being
submitted to the Fund is not increasing, and quite possibly is decreasing.
The Fund could usefully do more in encouraging other institutions to offer
technical assistance to countries that wish to obtain Global Fund financing.
* ANALYSIS: Round Three Decisions
A list is provided showing all eligible applications received in Round 3,
with the board's decision in each case. Also shown are countries that were
eligible to apply but did not do so.
+ + + + + + + + + + + + + + + + + + +
NEWS: Global Fund Approves Third Round of Grants, and Prepares for Round 4
+ + + + + + + + + + + + + + + + + + +
At its board meeting in Chiang Mai, Thailand, on October 15-17, the Global
Fund board approved 71 grants that will cost $623 million over the first two
years. (For a complete list of approved and rejected proposals, see
"Analysis: Round Three Decisions," below.)
The cost of the approved grants was significantly less than had been
expected, and was 30% less than in Round 2. This was for three reasons:
fewer proposals than expected were submitted; most of these were modest in
size; and a smaller percentage than expected were approved.
The board meeting also agreed that Round 4 will be launched on 10 January
2004, with applications to be submitted by about the end of March and
approvals to be made at the board meeting in June. It appears likely that
Round 4 will be the only Round in 2004, and it is far from certain that
there will be any new Round in 2005, because first priority that year will
go to renewing Round 1 and 2 grants.
The board meeting in Chiang Mai went fairly smoothly. Many participants,
including from NGOs and developing countries, praised the way in which
Chairman Tommy Thompson ran the meeting fairly and efficiently.
The Fund issued the following press release on 16 October:
GLOBAL FUND COMMITS US$623 MILLION TO NEW GRANTS TO FIGHT AIDS, TB AND
MALARIA
Chiang Mai ? Meeting in Thailand, the Board of the Global Fund to Fight
AIDS, Tuberculosis and Malaria approved $623 million in new two-year grants
to programs fighting the three diseases. This brings the total amount
approved by the Board after three proposal rounds to US$2.1 billion to 125
countries.
"In less than two years the Global Fund has become a leading force in the
fight against these three deadly diseases," said Tommy G. Thompson, United
States Secretary of Health and Human Services and Chair of the Global Fund's
Board. "Working with its partners, the Global Fund is beginning to realize
our commitment to prevention and treatment at a global scale."
To cover the amount recommended for the third round of proposals, the Board
committed to fully funding the round by deferring until January 2004 formal
confirmation of a portion of proposals totaling $138 million out of the
US$623 million. Almost all proposals require additional technical
clarifications before funds are legally obligated.
In addition, the Board agreed to consider a fourth round of proposals for
approval at its meeting in June 2004, with guidelines and proposal forms to
be issued in January.
At the Board Meeting, people living with HIV and international partners,
including the World Health Organization and UNAIDS, affirmed the health
emergency arising from inadequate treatment of HIV. Donors and recipients
affirmed the need to make new commitments quickly and agreed on a calendar
for the next round.
"At this meeting, Members of the Board worked together towards a common
vision of the Global Fund as a major instrument in the world's fight against
these diseases," said Dr Richard Feachem, the Global Fund's Executive
Director. "Their concerns challenge us to do our work better, and to do more
to help the millions in need of support. Agreement by the Board on fully
funding Round 3 and quickly launching Round 4 is an important step forward."
About 60% of the funds approved are targeted at HIV/AIDS, and about the same
are destined for Africa. In total, 57% will be awarded to non-governmental
partners, who work with governments as part of public-private partnerships
called Country Coordinating Mechanisms that develop and submit proposals to
the Global Fund. Over the lifetime of the programs (two years with the
possibility of renewals for another three years based on performance), they
will increase the number of people living with HIV on antiretrovirals by
nearly 200,000 and allow for nearly 7 million people to access HIV voluntary
counseling and testing services. 18 million insecticide-treated nets to
prevent malaria transmission will be purchased with the latest approved
funds, and 760,000 treatments will be provided for tuberculosis.
In aggregate, the US$2.1 billion committed by the Global Fund to date is
characterized as follows, with additional information available on the
website:
By region: 60% Africa; 20% Asia, Middle East and North Africa; 11% Latin
America and the Caribbean; and 9% Eastern Europe.
By disease: 60% HIV/AIDS; 23% malaria; and 17% tuberculosis (with some funds
to joint disease proposals).
By expenditure target: 46% drugs & commodities; 25% human resources and
training; 15 physical infrastructure; 5% monitoring & evaluation; 4%
administrative costs; and 5% other.
By recipient: 50% government; 29% non-governmental and community-based
organizations; 5% private sector; 4% faith-based organizations; 3% people
living with the diseases; 3% academic institutions; 6% other.
***
The Global Fund is a unique cooperative endeavor between private and public
partners to advance global public health by improving underlying health
systems, by enabling multi-sector strategies and by investing in local
capacity ? all focused by the urgent need to prevent and treat the three
major infectious diseases of our time.
As a partnership of national governments from both donor and developing
countries, non-governmental organizations, affected communities,
corporations, foundations and international organizations, the Global Fund
is well positioned to complement existing domestic, bilateral and
multilateral initiatives with a major influx of new finances. As a
grant-making organization, the Global Fund has adopted a rigorous,
businesslike framework to attract, manage and invest substantial resources
in countries and communities where these three diseases have already reached
or are threatening to reach epidemic proportions.
[End of press release]
+ + + + + + + + + + + + + + + + + + +
COMMENTARY: The Need for Technical Assistance
by Bernard Rivers
+ + + + + + + + + + + + + + + + + + +
Long before Round 3 took place, the Secretariat projected that the cost of
Years 1-2 of grants approved in Round 3 would be about $1,600 m., almost
double the cost of Round 2. As it turned out, the cost of Round 3 approved
grants came to only $623 m., which is almost 30% *less* than in Round 2.
This was caused, in part, by the fact that the percentage of proposals
recommended by the Technical Review Panel (TRP) for approval went down.
This strongly suggests that the technical merit of proposals being submitted
to the Fund is not increasing, and quite possibly is decreasing.
Contributory reasons might be that the countries most capable of submitting
good applications had already done so in Rounds 1 and 2; that these
countries are not yet ready to submit applications for follow-up projects
(or don't realize that the Fund is very open to additional proposals being
submitted long before earlier projects have been completed); and that some
applicants ? particularly some NGOs and regional organizations ? simply
don't understand that the type of application they are submitting has almost
no chance of being recommended by the TRP.
Behind every rejected proposal is a sad story. It is not unknown for
Ministries of Health almost to come to a halt while they race to complete a
Global Fund proposal. There are also sad stories behind countries that have
never applied, or that were rejected once and did not try again.
Clearly, therefore, there is a strong need to increase the quality and
availability of Technical Assistance to help applicants with deciding
whether to apply, with crafting their actual applications to the Fund, and
with thinking through the underlying strategy. In addition, as more and
more countries get launched on the actual implementation of their Global
Fund projects, there is an increasing need for Technical Assistance
regarding project relationships (e.g. between Principal Recipient and
sub-recipients) and project implementation. Finally, many CCMs are
inefficient, and/or are mere extensions of governments. Help is needed to
overcome these problems.
The Global Fund is a financing mechanism; it does not have sufficient
staffing to provide technical assistance. But it could usefully do more in
encouraging multi-lateral and bilateral institutions, NGOs, companies and
academic institutions to offer technical assistance to countries that wish
to obtain Global Fund financing.
[Bernard Rivers (rivers@aidspan.org) is Executive Director of Aidspan and
Editor of its GFO Newsletter.]
+ + + + + + + + + + + + + + + + + + +
ANALYSIS: Round Three Decisions
+ + + + + + + + + + + + + + + + + + +
The following table lists all countries eligible to apply for Global Fund
grants. For each country, the table shows the applicant, the components
(HIV/AIDS, TB, Malaria, or HIV plus TB) for which a Round 3 grant was
requested, and the board's decision. Also shown are eligible multi-country
applications.
The meanings of Categories 1, 2A, 2B, 3 and 4 are explained at the end of
the table.
Afghanistan -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $2,439,177
Afghanistan -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $4,150,960
Afghanistan -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $5,941,748
Albania -- CCM did not apply
Algeria -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $6,185,000
Angola -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $19,067,584
Angola -- Applicant=CCM; Component=Malaria:
Approved (Category 2B) -- 2-year grant: $25,259,000
Angola -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $4,184,487
Armenia -- CCM did not apply
Azerbaijan -- CCM did not apply
Bangladesh -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $11,456,195
Bangladesh -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $13,532,089
Bangladesh -- Applicant=CCM; Component=TB:
Approved (Category 2B) -- 2-year grant: $17,169,684
Barbados -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $9,208,353
Belarus -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $6,818,796
Belize -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $1,298,884
Benin -- Applicant=CCM; Component=Malaria:
Approved (Category 2B) -- 2-year grant: $1,383,931
Bhutan -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $412,700
Bhutan -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $395,000
Bolivia -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $6,019,023
Bolivia -- Applicant=CCM; Component=Malaria:
Approved (Category 2B) -- 2-year grant: $6,099,563
Bolivia -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $2,381,646
Bosnia and Herzegovina -- CCM did not apply
Botswana -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $2,243,500
Bulgaria -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,013,280
Burkina Faso -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $827,120
Burundi -- CCM did not apply
Cambodia -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $14,731,002
Cambodia -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $3,865,042
Cameroon -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $14,641,407
Cameroon -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $16,938,794
Cameroon -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $2,986,220
Cape Verde -- CCM did not apply
Central African Republic -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $7,741,975
Central African Republic -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,687,749
Chad -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $7,380,156
Chad -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $3,028,688
China -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $32,122,550
Colombia -- CCM did not apply
Comoros -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $751,700
Congo (Democratic Rep.) -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $34,799,786
Congo (Democratic Rep.) -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $24,966,676
Congo (Republic) -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $8,242,988
Congo (Republic) -- Applicant=an NGO; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $3,325,000
Cote d'Ivoire -- Applicant=an NGO; Component=HIV/AIDS:
Approved (Category 1) -- 2-year grant: $1,023,534
Cote d'Ivoire -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $9,855,759
Cote d'Ivoire -- Applicant=CCM; Component=TB:
Approved (Category 2B) -- 2-year grant: $2,877,316
Cuba -- CCM did not apply
Djibouti -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $5,807,900
Djibouti -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $2,274,390
Djibouti -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,291,000
Dominican Republic -- Applicant=CCM; Component=Malaria:
Rejected (Category 4) -- 2-year request: $2,034,530
Dominican Republic -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $2,636,816
East Timor -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $967,650
Ecuador -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $4,565,029
Ecuador -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $5,977,416
Egypt -- CCM did not apply
El Salvador -- CCM did not apply
Equatorial Guinea -- CCM did not apply
Eritrea -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $8,124,910
Eritrea -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,486,180
Ethiopia -- CCM did not apply
Fiji -- CCM did not apply
Gabon -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $3,154,500
Gabon -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $1,004,778
Gabon -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $604,000
Gambia -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $6,241,743
Gambia -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $5,665,500
Gambia -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $6,220,664
Georgia -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $645,700
Ghana -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $16,707,652
Ghana -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $21,921,387
Ghana -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $13,071,408
Guatemala -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $8,423,807
Guinea -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $3,488,280
Guinea-Bissau -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $4,129,958
Guinea-Bissau -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $2,755,057
Guinea-Bissau -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $1,503,587
Guyana -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $9,486,122
Guyana -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $2,055,675
Haiti -- Applicant=CCM; Component=Malaria:
Approved (Category 2B) -- 2-year grant: $7,390,556
Haiti -- Applicant=CCM; Component=TB:
Approved (Category 1) -- 2-year grant: $8,131,836
Honduras -- CCM did not apply
India -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $38,390,000
India -- Applicant=CCM; Component=HIV/TB:
Approved (Category 2A) -- 2-year grant: $2,667,346
India -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $42,883,376
Indonesia -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $23,101,000
Iran (Islamic Rep. of) -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $4,000,000
Iran (Islamic Rep. of) -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $3,299,697
Iraq -- CCM did not apply
Iraq -- Applicant=a regional org.; Component=Integrated
Rejected (Category 4) -- 2-year request: $9,463,037
Jamaica -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $7,560,365
Jordan -- CCM did not apply
Kazakhstan -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $5,393,118
Kenya -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $58,004,104
Kenya -- Applicant=CCM; Component=Integrated
Rejected (Category 4) -- 2-year request: $25,092,923
Kenya -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $1,812,250
Kiribati -- CCM did not apply
Korea (Dem. Peoples Rep. of) ?
Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $3,227,300
Kyrgyzstan -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $785,000
Laos -- CCM did not apply
Latvia -- Applicant=CCM; Component=Not known
Rejected (Not eligible)
Latvia -- Applicant=CCM; Component=Not known
Rejected (Not eligible)
Lesotho -- CCM did not apply
Liberia -- Applicant=CCM; Component=Malaria:
Approved (Category 1) -- 2-year grant: $12,140,921
Macedonia (The Former Yugoslav Republic of) ?
Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $4,348,599
Macedonia (Former Yugoslav Rep. of) ?
Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,142,500
Madagascar -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $13,415,118
Madagascar -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $5,232,448
Madagascar -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,681,016
Malawi -- CCM did not apply
Malaysia -- CCM did not apply
Maldives -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $1,005,100
Mali -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $17,492,950
Marshall Islands -- CCM did not apply
Mauritania -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $2,445,256
Mexico -- Applicant=CCM; Component=HIV/TB:
Rejected (Not eligible)
Micronesia -- CCM did not apply
Moldova -- CCM did not apply
Mongolia -- CCM did not apply
Morocco -- CCM did not apply
Mozambique -- CCM did not apply
Multi-country Africa (AMREF) --
Applicant=a regional org.; Component=HIV/TB:
Rejected (Category 4) -- 2-year request: $2,566,176
Multi-country Africa (ECSA Health Community Secretariat) --
Applicant=a regional org.; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $3,077,000
Multi-country Africa (HACI) --
Applicant=a regional org.; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $15,477,500
Multi-country Africa (HPI) --
Applicant=a regional org.; Component=Malaria:
Rejected (Category 4) -- 2-year request: $21,747,000
Multi-country Africa (IFRCRC) --
Applicant=a regional org.; Component=Malaria:
Rejected (Category 4) -- 2-year request: $51,179,486
Multi-country Africa (IFRCRC) --
Applicant=a regional org.; Component=Malaria:
Rejected (Category 4) -- 2-year request: $7,980,458
Multi-country Africa (MIPESA) --
Applicant=a regional org.; Component=Malaria:
Rejected (Category 3) -- 2-year request: $3,033,458
Multi-country Africa (Presbyterian Church) --
Applicant=a regional org.; Component=Malaria:
Rejected (Category 4) -- 2-year request: $1,123,580
Multi-country Africa (WorldTeach) --
Applicant=a regional org.; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $34,170,415
Multi-country Americas (Andean) --
Applicant=a regional org.; Component=Malaria:
Rejected (Category 3) -- 2-year request: $15,909,000
Multi-country Americas (OECS) ?
Applicant=a regional org.; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year request: $2,553,861
Multi-country Americas (PANCAP) ?
Applicant=a regional org.; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $6,100,900
Multi-country Portuguese speaking ?
Applicant=a regional org.; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $12,773,451
Multi-country South East Asia (TROPMED) ?
Applicant=a regional org.; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $4,125,894
Myanmar -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $19,221,525
Myanmar -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $9,462,062
Namibia -- CCM did not apply
Nepal -- CCM did not apply
Nicaragua -- CCM did not apply
Niger -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $8,475,297
Niger -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $4,815,109
Niger -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,867,084
Nigeria -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $87,783,683
Pakistan -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $6,138,487
Pakistan -- Applicant=CCM; Component=HIV/TB:
Rejected (Category 4) -- 2-year request: $314,000
Pakistan -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $1,548,636
Pakistan -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $6,768,734
Panama -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $8,075,594
Papua New Guinea -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $2,290,000
Papua New Guinea -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $6,106,556
Paraguay -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $9,811,763
Paraguay -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $1,194,902
Peru -- CCM did not apply
Philippines -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $3,496,865
Romania -- CCM did not apply
Russian Federation -- Applicant=an NGO; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $31,596,308
Russian Federation -- Applicant=a Sub-CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $3,492,841
Russian Federation -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $24,076,047
Russian Federation -- Applicant=a Sub-CCM; Component=TB:
Approved (Category 2B) -- 2-year grant: $6,341,210
Russian Federation -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $24,298,048
Rwanda -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $14,890,735
Rwanda -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $13,045,301
Saint Vincent and the Grenadines -- CCM did not apply
Samoa -- CCM did not apply
Sao Tome and Principe -- Applicant=CCM; Component=HIV/TB:
Rejected (Category 3) -- 2-year request: $2,139,658
Sao Tome and Principe -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $1,975,026
Senegal -- CCM did not apply
Serbia -- Applicant=a Sub-CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $1,909,799
Serbia -- Applicant=CCM; Component=TB:
Approved (Category 1) -- 2-year grant: $2,428,986
Sierra Leone -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $10,855,343
Sierra Leone -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $4,154,607
Slovakia (Slovak Rep.) -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Not eligible)
Solomon Islands -- CCM did not apply
Somalia -- Applicant=an NGO; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $2,950,000
Somalia -- Applicant=an NGO; Component=Malaria:
Rejected (Category 3) -- 2-year request: $588,000
Somalia -- Applicant=CCM; Component=TB:
Approved (Category 1) -- 2-year grant: $5,601,215
Somalia -- Applicant=an NGO; Component=TB:
Rejected (Category 3) -- 2-year request: $2,955,000
South Africa -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $15,521,456
South Africa -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $8,553,624
South Africa -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $23,136,451
South Africa -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $2,668,769
South Africa -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $69,898,308
South Africa -- Applicant=CCM; Component=HIV/TB:
Rejected (Category 3) -- 2-year request: $9,062,250
South Africa -- Applicant=CCM; Component=HIV/TB:
Rejected (Category 4) -- 2-year request: $30,443,293
South Africa -- Applicant=CCM; Component=HIV/TB:
Rejected (Category 4) -- 2-year request: $776,000
South Africa -- Applicant=CCM; Component=HIV/TB:
Rejected (Category 4) -- 2-year request: $5,698,953
South Africa -- Applicant=CCM; Component=Integrated
Rejected (Category 3) -- 2-year request: $57,069,854
South Africa -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $7,688,722
South Africa -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $14,996,075
Sri Lanka -- CCM did not apply
Sudan -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $7,842,140
Sudan -- Applicant=a Sub-CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $25,585,580
Sudan -- Applicant=a Sub-CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $18,810,078
Sudan -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $2,993,000
Sudan -- Applicant=a Sub-CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $4,809,284
Suriname -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $2,188,432
Suriname -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $2,775,330
Swaziland -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $1,348,400
Syrian Arab Republic -- CCM did not apply
Tajikistan -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $913,418
Tajikistan -- Applicant=CCM; Component=Malaria:
Rejected (Category 3) -- 2-year request: $1,835,399
Tajikistan -- Applicant=CCM; Component=TB:
Approved (Category 2B) -- 2-year grant: $1,521,040
Tanzania/Zanzibar -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $959,482
Tanzania -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $3,495,249
Tanzania -- Applicant=CCM; Component=HIV/TB:
Approved (Category 2A) -- 2-year grant: $23,951,034
Thailand -- CCM did not apply
Thailand -- Applicant=an NGO; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $911,542
Togo -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $3,479,337
Togo -- Applicant=CCM; Component=TB:
Approved (Category 2A) -- 2-year grant: $1,752,982
Tonga -- CCM did not apply
Trinidad and Tobago -- CCM did not apply
Tunisia -- CCM did not apply
Turkey -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 4) -- 2-year request: $6,975,950
Turkey -- Applicant=CCM; Component=Malaria:
Rejected (Category 4) -- 2-year request: $235,150
Turkey -- Applicant=CCM; Component=TB:
Rejected (Category 4) -- 2-year request: $1,292,860
Turkmenistan -- CCM did not apply
Uganda -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2A) -- 2-year grant: $70,357,632
Ukraine -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $27,804,760
Uzbekistan -- Applicant=CCM; Component=HIV/AIDS:
Approved (Category 2B) -- 2-year grant: $5,182,832
Uzbekistan -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $14,639,371
Vanuatu -- CCM did not apply
Vietnam -- Applicant=CCM; Component=Malaria:
Approved (Category 2A) -- 2-year grant: $13,388,402
West Bank and Gaza -- CCM did not apply
Yemen -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $5,500,405
Yemen -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $1,073,925
Zambia -- CCM did not apply
Zimbabwe -- Applicant=CCM; Component=HIV/AIDS:
Rejected (Category 3) -- 2-year request: $56,057,370
Zimbabwe -- Applicant=CCM; Component=TB:
Rejected (Category 3) -- 2-year request: $6,382,377
The meanings of the Categories are as follows:
* Category 1: Approved proposals for which the Technical Review Panel (TRP)
sought no clarifications or only minor ones. Clarifications must be
provided within 4 weeks. Final approval of clarifications must be issued by
the TRP Chair and/or Vice-Chair.
* Category 2: Approved proposals for which the TRP sought a number of
clarifications. Clarifications must be provided within 6 weeks. Any
follow-up queries must be answered and finally approved by the TRP within 3
to 4 months. Approval of clarifications must be issued by the TRP Chair
and/or Vice-Chair, plus the TRP primary and secondary reviewers.
Note: Proposals assigned to Category 2 were sub-divided into sub-Categories
2A and 2B, based on how many clarifications were needed. All these
proposals were approved, but for technical reasons, approval of the Category
2B proposals only takes full effect in January 2004. At a practical level,
this difference has no impact. All applicants whose proposals were approved
(i.e. whose proposals fell into Categories 1, 2A and 2B) will be asked to
answer the clarifications and then to negotiate grant agreements during the
remainder of 2003.
* Category 3: Proposals not recommended in their present form, but regarding
which applicants are encouraged to submit improved applications in future
Rounds.
* Category 4: Proposals not recommended for funding, and regarding which the
TRP provides no encouragement that applicants should re-apply in future
Rounds.
Further details on all the above grants should be available at
www.aidspan.org in the course of Tuesday October 21.
The table below shows that between Round 2 and Round 3, the percentage of
eligible proposals that were approved went down from 43% to 39%, and the
dollar value of the approved proposals went down from 41% to 34% of the
value of all eligible proposals.
Table: Approval Rates in Rounds 1, 2 and 3
+???????-???????????-+???????????+?????-+??????????---+???????-+
| | Number of | % | Cost of | % |
| | eligible | | Years 1-2 | |
| | proposals | | | |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
| Round 1: Submitted | 204 | 100% | c. $1,500 m.| 100% |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
| Of which, Approved| 58 | 28% | $578 m.| c. 39% |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
| Round 2: Submitted | 229 | 100% | $2,137 m.| 100% |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
| Of which, Approved| 98 | 43% | $878 m.| 41% |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
| Round 3: Submitted | 180 | 100% | $1,853 m.| 100% |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
| Of which, Approved| 71 | 39% | $623 m.| 34% |
+???????-???????????-+???????????+?????-+??????????--?+???????-+
+ + + + + + + + + + + + + + + + + + +
END OF NEWSLETTER
+ + + + + + + + + + + + + + + + + + +
This is an issue of the GLOBAL FUND OBSERVER (GFO) NEWSLETTER.
The GFO NEWSLETTER is an independent source of news, analysis and commentary
about the Global Fund to Fight AIDS, TB and Malaria (www.globalfundatm.org).
The GFO Newsletter is emailed to subscribers once or twice a month. It is
closely linked to the GFO DISCUSSION FORUM (see below).
GFO has an Editorial Advisory Board initially comprising ICASO, GNP+ and the
AIDS NGO Network in East Africa (the three organizations designated as
Communications Focal Points within the Global Fund's NGO board delegations);
plus Health & Development Networks (founder of the Break-The-Silence
listserv, which originally covered the Global Fund); and the International
HIV/AIDS Alliance. GFO is currently provided in English only. It is hoped
later to provide it in additional languages.
GFO is a free service of Aidspan (www.aidspan.org), based in New York, USA.
GFO and Aidspan have no formal connection with, and will accept no grants or
fees from, the Global Fund. Aidspan is a nonprofit organization that
promotes increased support for, and effectiveness of, the Global Fund.
GFO Editor: Bernard Rivers (rivers@aidspan.org, +1-212-662-6800)
Reproduction of articles in the Newsletter is permitted if the following is
stated: "Reproduced from the Global Fund Observer Newsletter
(www.aidspan.org/gfo), a service of Aidspan."
* To stop receiving the GFO NEWSLETTER, send an email to
stop-gfo-newsletter@aidspan.org
Subject line and text can be left blank.
* To receive the GFO NEWSLETTER (if you haven't already subscribed), send an
email to
receive-gfo-newsletter@aidspan.org
Subject line and text can be left blank. (You will receive about two issues
per month.)
* To join the GFO DISCUSSION FORUM, send an email to
join-gfo-forum@aidspan.org
Subject line and text can be left blank. The Forum provides an opportunity
for subscribers to share information, express opinions, seek advice, and
respond to articles in the GFO Newsletter. (Subscribers automatically
receive the Newsletter.)
* For GFO background information, see
www.aidspan.org/gfo
* For previous issues of the GFO Newsletter and Discussion Forum, see
www.aidspan.org/gfo/archives
* For a definitive collection of papers on the Global Fund, see
www.aidspan.org/globalfund
Copyright (c) 2003 Aidspan. All rights reserved.
Pour vous inscrire, vous désinscrire et consulter les archives de e-med :
http://www.essentialdrugs.org/emed/
--
Adresse pour les messages destinés au forum E-MED:
e-med@healthnet.org
Pour répondre à un message envoyer la réponse au forum
ou directement à l'auteur.
Pour toutes autres questions addresser vos messages à :
e-med-help@healthnet.org
|
